hrp0092p3-17 | Adrenals and HPA Axis | ESPE2019
, Pedicelli Stefania
, Ventresca Silvia
, Desideri Elena
, Stella Marcello
Background: Newborn screening for congenital adrenal hyperplasia (CAH) is based on the determination of 17-hydroxyprogesterone (17OHP) on blood and its need is confirmed by the most recent guidelines on the subject. In Italy this screening is not mandatory, and its application is on a regional basis. Among its disadvantages, it is well known the high frequency of false-positives, in particular in premature babies and those born small for gestational age. Howev...